Brianna “Chickenfry” LaPaglia slams using Ozempic for weight loss.
The 26-year-old reality TV star and Barstool Sports personality opened up about her increasing use of GLP-1 weight loss drugs, such as Ozempic, on TikTok on March 10, saying everyone she knew was using the drug.
“This is no tea, no shade, no hate — just some field research,” LaPaglia said in the video. “Every (expletive) I know is on Ozempic. The ones who don’t need Ozempic, okay?”
Even people “who don’t need Ozempic” are using the drug, LaPaglia asserted, adding “it’s like I’m taking Ozempic.” She added that while she “might lose a couple,” she doesn’t need Ozempic.
“You’re going to die. You’re all going to die,” LaPaglia said, ending her video.
From Golden Globes to breakups: Zach Bryan and Brianna “Chickenfry” LaPaglia Controversy
Brianna LaPaglia attends the LaQuan Smith fashion show during New York Fashion Week on February 14, 2026 in New York City.
GLP-1 use on the rise in U.S.
Use of GLP-1 drugs, including Ozempic, more than doubled among men and women between 2024 and 2025, with 12.4% of respondents admitting to taking the drugs, up from 5.8% in February 2024, when the research firm originally measured it, according to a survey released Oct. 28 by the Gallup National Health & Wellbeing Index.
The drugs, approved by the U.S. Food and Drug Administration for weight loss in 2021, are booming as an effective way to lose weight and reduce food intake by extending satiety, USA Today previously reported.
GLP-1 drugs: What exactly are they and how do they work?
What are the side effects of GLP-1 drugs?
However, weight loss medications are not without side effects, which can include nausea or vomiting, diarrhea or constipation, heartburn or bloating, fatigue, dehydration, and muscle loss. Patients taking higher doses long-term may also experience hair thinning, especially when combined with low caloric intake. Less common but serious side effects include acute pancreatitis (inflammation of the pancreas), gallbladder problems, and blindness, which require immediate medical attention.
Several GLP-1 manufacturers, including Novo Nordisk, the Danish maker of Ozempic, Wegovy, Rybelsus, Victoza and Saxenda, and Indiana-based Eli Lilly, which makes Trulicity, Mounjaro and Zepbound, are also facing multiple lawsuits alleging that the drugmakers failed to adequately warn about the risks of certain serious injuries, USA Today previously reported.
The first such case was filed in 2023, and since then at least 4,400 patients have filed lawsuits that are now part of a consolidated federal and state lawsuit, with numbers expected to grow.
GLP-1 Litigation: What are their charges?
Other celebrities promote the use of GLP-1
While LaPaglia opposes the use of diet pills, “The View” co-hosts, including guest Savannah Chrisley, spoke last month about the drug and how it changed their lives.
“We’ve all done it,” adds Joy Behar, who admitted to losing 25 pounds with GLP-1, “and it’s all on this table.”
“GLP-1 is cool,” Chrisley added.
Other celebrities who have spoken out about using diet pills to lose weight include Serena Williams, Rebel Wilson, Andy Cohen and Oprah Winfrey.
Williams said she had tried everything she could to reach a healthy weight, but had not been successful until taking the GLP-1 drug.
“One misconception is that this is a shortcut,” she said earlier. “As an athlete, as someone who’s done it all, I just couldn’t get my weight to a healthy level – trust me, I’m not taking shortcuts.”
Serena Williams as Ro
Winfrey, meanwhile, said she started taking GLP-1 when she realized obesity was not a lack of discipline or willpower but a disease that needed treatment. She knew the drugs would be “a lifelong thing,” sometimes given every 10 to 12 days instead of weekly because she could still feel the effects of her last shot.
While Winfrey experienced some side effects, such as digestive issues, she said the inconvenience was worth it.
“I feel more alive and energetic than ever,” Winfrey said.
If you or someone you know is struggling with body image or eating issues, the National Eating Disorders Association’s toll-free confidential helpline is available by phone or text message at 1-800-931-2237 or by clicking on a chat message Nationaleatingdisorders.org/helpline. For 24/7 crisis situations, text “NEDA” to 741-741.
Saman Shafiq is a popular news reporter for USA Today. Contact her at sshafiq@usatodayco.com and follow her on X and Instagram @saman_shafiq7.
This article originally appeared on USA TODAY: Brianna LaPaglia slams Ozempic use, says everyone she knows is using it
